Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 146 entries
View as:

Pulsed Perfusion for Marginal Kidneys

Phase: N/A Priority: Normal
NCT ID: NCT02055950 Org: User:
Start: 07/31/13 End: 08/31/18 Due: 08/31/19

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

Phase: N/A Priority: Normal
NCT ID: NCT06126315 Org: User:
Start: 03/26/25 End: 09/30/27 Due: 09/30/28

Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02249702 Org: User:
Start: 04/30/10 End: 04/30/17 Due: 04/30/18

Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01052389 Org: User:
Start: 07/31/07 End: 06/30/13 Due: 06/30/14

GREAT - Good Response With Appropriate Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02293785 Org: User:
Start: 11/30/14 End: 02/29/16 Due: 02/28/17

Diadem to Investigate the Activity and Safety of Durvalumab

Phase: N/A Priority: Normal
NCT ID: NCT04115111 Org: User:
Start: 10/17/18 End: 05/16/19 Due: 05/16/20

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients

Phase: N/A Priority: Normal
NCT ID: NCT05976477 Org: User:
Start: 10/01/23 End: 12/31/25 Due: 12/31/26

Selection of People at Low Cardiovascular Risk: Development of an Inexpensive Pre-screening Algorithm Using Only Non-laboratory Measures. The SKIM Risk Study.

Phase: N/A Priority: Normal
NCT ID: NCT03962309 Org: User:
Start: 12/18/20 End: 08/31/24 Due: 08/31/25

Outcome of ADPKD With Octreotide LAR

Phase: N/A Priority: Normal
NCT ID: NCT06193616 Org: User:
Start: 02/12/24 End: 06/30/25 Due: 06/30/26

Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT01265342 Org: User:
Start: 10/31/10 End: 10/31/12 Due: 10/31/13

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05805202 Org: User:
Start: 05/03/23 End: 06/30/25 Due: 06/30/26

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03358004 Org: User:
Start: 06/14/17 End: 09/13/18 Due: 09/13/19

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00309257 Org: User:
Start: 01/31/04 End: 10/31/09 Due: 10/31/10

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT01946555 Org: User:
Start: 09/30/13 End: 12/31/15 Due: 12/31/16

Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)

Phase: N/A Priority: Normal
NCT ID: NCT03689114 Org: User:
Start: 05/10/21 End: 08/31/24 Due: 08/31/25

Effects of Caloric Restriction in Obesity and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01930136 Org: User:
Start: 05/31/13 End: 05/05/22 Due: 05/05/23

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01379989 Org: User:
Start: 06/30/11 End: 12/17/20 Due: 12/17/21

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01379976 Org: User:
Start: 04/30/11 End: 10/31/14 Due: 10/31/15

The European Tinnitus Survey: a Study on Tinnitus Prevalence in 12 European Countries

Phase: N/A Priority: Normal
NCT ID: NCT04892095 Org: User:
Start: 06/01/17 End: 10/30/18 Due: 10/30/19

Real Time Amplitude Spectrum Area to Guide Defibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03237910 Org: User:
Start: 04/28/19 End: 07/26/21 Due: 07/26/22

Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04765709 Org: User:
Start: 09/24/21 End: 06/30/26 Due: 06/30/27

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03358017 Org: User:
Start: 03/05/18 End: 07/25/23 Due: 07/25/24

E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF

Phase: N/A Priority: Normal
NCT ID: NCT03188211 Org: User:
Start: 09/01/17 End: 09/30/18 Due: 09/30/19

CardioPulmonary Resuscitation With Argon (CPAr) Trial

Phase: N/A Priority: Normal
NCT ID: NCT05482945 Org: User:
Start: 05/30/22 End: 06/30/26 Due: 06/30/27

COVID-19 Impact on the Lombardy Region's Emergency System

Phase: N/A Priority: Normal
NCT ID: NCT04669925 Org: User:
Start: 09/01/20 End: 01/15/22 Due: 01/15/23